Table 2.
Studies Reporting a Liver Injury in Patients With Coronavirus Infection 19 (COVID 19).
| Author, year | Total number of patients | Proportion with preexisting liver disease | Manifestations |
|---|---|---|---|
| Guan W, 202011 | 1099 | 23 (2.3%) | Elevation of AST 168/757 (22.2%) ALT 158/741 (21.3%) TB 76/722 (10.5%) |
| Cai Q, 202031 | 298 | 8 (2.7%) | 44 (14.8%) More in patients with severe disease (36.2%) than those with mild disease (9.6%) |
| Fan Z, 202032 | 148 | NA | 75 (50.7%) |
| Wang D, 202033 | 138 | 4 (2.9%) | Mild AST elevation, particularly in patients with severe disease |
| Chen N, 20208 | 99 | NA | Abnormality in ALT 28 (28%) AST 35 (35%) TB 18 (18%) Low albumin 97 (98%) |
| Shi H, 202034 | 81 | 7 (9%) | 43 (53%) |
| Xu X, 202035 | 62 | 7 (11%) | 10 (16.1%) |
| Yang X, 202036 | 52 | NA | 15 (29%) |
| Huang C, 20207 | 41 | 1 (2%) | 15 (31%) |
| Zhang B, 202037 | 82 | 2 (2.4%) | 64 (78%) |
| Huang Y, 202037 | 36 | NA | Elevation of ALT 4/30 (13.33%) AST 18/31 (58.06%) TB 4/31 (12.90%) |
| Cholankeril G, 202017 | 116 | Abnormal LFT 26/65 (40%) | |
| Wu J, 202038 | 80 | NA | 3 (3.75%) |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; TB, total bilirubin; LFT, liver function test; NA, not available.